As of 2026-09-10, the Relative Valuation of Immunovant Inc (IMVT) is (71.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.75 USD, the upside of Immunovant Inc based on Relative Valuation is -283.7%.
The range of the Relative Valuation is (63.37) - (78.23) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 24.2x - 30.0x | 27.1x |
| Forward P/E multiples | 24.3x - 30.7x | 27.5x |
| Fair Price | (63.37) - (78.23) | (71.19) |
| Upside | -263.5% - -301.9% | -283.7% |
| Date | P/E |
| 2026-09-08 | -15.17 |
| 2026-09-04 | -15.05 |
| 2026-09-03 | -15.00 |
| 2026-09-02 | -15.14 |
| 2026-09-01 | -15.30 |
| 2026-08-31 | -15.65 |
| 2026-08-28 | -15.80 |
| 2026-08-27 | -16.80 |
| 2026-08-26 | -16.83 |
| 2026-08-25 | -16.68 |
| 2026-08-24 | -16.61 |
| 2026-08-21 | -17.02 |
| 2026-08-20 | -17.01 |
| 2026-08-19 | -17.24 |
| 2026-08-18 | -16.99 |
| 2026-08-17 | -16.76 |
| 2026-08-14 | -16.04 |
| 2026-08-13 | -16.04 |
| 2026-08-12 | -16.34 |
| 2026-08-11 | -15.70 |
| 2026-08-10 | -15.30 |
| 2026-08-07 | -15.32 |
| 2026-08-06 | -15.24 |
| 2026-08-05 | -15.06 |
| 2026-08-04 | -15.09 |
| 2026-08-03 | -14.77 |
| 2026-07-31 | -14.81 |
| 2026-07-30 | -15.14 |
| 2026-07-29 | -14.81 |
| 2026-07-28 | -14.92 |
| 2026-07-27 | -15.37 |
| 2026-07-24 | -15.11 |
| 2026-07-23 | -15.10 |
| 2026-07-22 | -14.98 |
| 2026-07-21 | -15.16 |
| 2026-07-20 | -15.31 |
| 2026-07-17 | -15.44 |
| 2026-07-16 | -14.94 |
| 2026-07-15 | -15.29 |
| 2026-07-14 | -14.87 |
| 2026-07-13 | -14.84 |
| 2026-07-10 | -15.23 |
| 2026-07-09 | -15.76 |
| 2026-07-08 | -15.46 |
| 2026-07-07 | -15.37 |
| 2026-07-06 | -14.80 |
| 2026-07-02 | -14.88 |
| 2026-07-01 | -14.63 |
| 2026-06-30 | -14.78 |
| 2026-06-29 | -14.77 |